startup
Zatannazatanna.ai
Zatanna transforms existing software into agent-first APIs, enabling seamless integration with AI agents.
- 机会评分
- 85 / 100
- 累计融资
- unknown
- 融资阶段
- unknown
- 成立年份
- 2026
- 地区
- Global
- 阶段
- pre-seed
八个维度
Company · Problem · Solution · Target Customer · Business Model · Funding · Competitors · Why NowCompany
Zatanna is a Y Combinator Winter 2026 company focused on transforming software into agent-first APIs. The platform enables developers to integrate AI agents with existing software systems more effectively.
Problem
Developers face challenges in integrating AI agents with existing software due to complex APIs and lack of standardization. This integration process is time-consuming and error-prone.
Solution
Zatanna provides a platform that automatically transforms existing software into agent-first APIs. This simplifies integration with AI agents and reduces development time.
Target Customer
The target customers are developers, engineering teams, and companies in the B2B software sector. The primary users are software developers and product managers.
Business Model
Zatanna plans to monetize through a subscription-based model for its API transformation platform. Revenue will also come from enterprise licensing agreements.
Funding
该维度暂无可核实信息(unknown)
Competitors
该维度暂无可核实信息(unknown)
Why Now
The rise of AI agents and the need for seamless integration with existing software systems create a timely opportunity for Zatanna's solution. Advances in API technology and increasing demand for AI integration drive this need.
来源与 AI 标注
模型 · prompt 版本 · 生成时间 · 来源链接相关项目与同赛道
按赛道继续看相关项目6 家
| 公司 | 赛道 | 评分 |
|---|---|---|
| ReboltAI驱动的企业操作系统 | AIB2B企业服务 | 95 |
| EliseAIAI-driven platform for enterprise efficiency and decision-making | AISaaS | 90 |
| TensorTestAI-powered creative task evaluation platform | AIB2BData | 90 |
| LucentAI that automatically improves products from user behavior. | B2BAIProductivity | 90 |
| Paratus HealthAI 驱动的医疗数据分析平台 | HealthcareAI | 90 |
| HealthKeyAI-Powered Patient Matching for Clinical Trials | AIHealthcareClinical Trials | 90 |
同赛道入口按赛道继续看
数据来自公开渠道与 AI 解读,仅供参考,不构成投资建议。信息可能滞后或有误,决策请以公司官网与官方披露为准。